In a matter of minutes, the Qvella blood analyzer is able to detect 90% of potentially harmful pathogens in the bloodstream that can then be isolated and treated. It is a transformative product that greatly reduces the speed at which infectious pathogens are detected in the body, and helps facilitate antimicrobial therapy much faster in critically ill patients.

This process uses Qvella’s FAST-Technology™ (Field Activated Sample Treatment), to isolate bloodstream infections. It includes preferential lysis of sample cells, rapid isolation and concentration of specific target cell types including pathogenic cells, and in-line e-Lysis™ that produces a clean, NAAT-ready lysate.